In this study, using syngeneic mouse colon cancer and melanoma models, we examined the effects of 6 common antidiabetic drugs on tumor inhibition of anti-PD1, including acarbose, sitagliptin, metformin, glimepiride, pioglitazone, and insulin. Here, INS is linked to malignant colon neoplasm.